Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Bris

Showing results (341-350 of 387) with videos related to

Pageof 39
Sort By:
Science (New York, N.Y.)|April 23, 2016
Response to Comments on "Slow adaptation in the face of rapid warming leads to collapse of the Gulf of Maine cod fishery"Andrew J Pershing, Michael A Alexander, Christina M Hernandez, et al.
British Journal of Haematology|November 9, 2018
A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patientsRobin Boutault, Pierre Peterlin, Marouane Boubaya, et al.
Haematologica|February 8, 2024
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifsJean Galtier, Louis Drevon, Yannick Le Bris, et al.
Bone Marrow Transplantation|January 31, 2017
Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adultsY Le Bris, T Guillaume, A Ménard, et al.
Hemasphere|August 28, 2023
Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in FranceMeryl Darlington, Pierre Sujobert, Olivier Kosmider, et al.
Pharmaceutics|July 29, 2023
Preclinical Evaluation of a <sup>64</sup>Cu-Based Theranostic Approach in a Murine Model of Multiple MyelomaCassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, et al.
American Journal of Hematology|December 22, 2017
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) studyOlivier Mansier, Damien Luque Paz, Jean-Christophe Ianotto, et al.
Ejhaem|July 18, 2022
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutationBaptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, et al.
Hemasphere|November 15, 2019
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid MalignanciesPierre Sujobert, Yannick Le Bris, Laurence de Leval, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell LymphomaVincent Rebière, Meriem Maajem, Ronan Le Calloch, et al.
Pageof 39

Showing results (341-350 of 387) with videos related to

Sort By:
Pageof 39
Science (New York, N.Y.)|April 23, 2016
Response to Comments on "Slow adaptation in the face of rapid warming leads to collapse of the Gulf of Maine cod fishery"Andrew J Pershing, Michael A Alexander, Christina M Hernandez, et al.
British Journal of Haematology|November 9, 2018
A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patientsRobin Boutault, Pierre Peterlin, Marouane Boubaya, et al.
Haematologica|February 8, 2024
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifsJean Galtier, Louis Drevon, Yannick Le Bris, et al.
Bone Marrow Transplantation|January 31, 2017
Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adultsY Le Bris, T Guillaume, A Ménard, et al.
Hemasphere|August 28, 2023
Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in FranceMeryl Darlington, Pierre Sujobert, Olivier Kosmider, et al.
Pharmaceutics|July 29, 2023
Preclinical Evaluation of a <sup>64</sup>Cu-Based Theranostic Approach in a Murine Model of Multiple MyelomaCassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, et al.
American Journal of Hematology|December 22, 2017
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) studyOlivier Mansier, Damien Luque Paz, Jean-Christophe Ianotto, et al.
Ejhaem|July 18, 2022
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutationBaptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, et al.
Hemasphere|November 15, 2019
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid MalignanciesPierre Sujobert, Yannick Le Bris, Laurence de Leval, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell LymphomaVincent Rebière, Meriem Maajem, Ronan Le Calloch, et al.
Pageof 39